# A Multicenter, Double-blind, Parallel Phase III Study

> **NCT02352584** · PHASE3 · COMPLETED · sponsor: **Green Cross Corporation** · enrollment: 1299 (estimated)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** GC3110A(Quadrivalent)
- **BIOLOGICAL:** GC Flu(Trivalent)
- **BIOLOGICAL:** GC3110A(Trivalent)

## Key facts

- **NCT ID:** NCT02352584
- **Lead sponsor:** Green Cross Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2014-12
- **Final completion:** 2015-07
- **Target enrollment:** 1299 (ESTIMATED)
- **Last updated:** 2015-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02352584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02352584, "A Multicenter, Double-blind, Parallel Phase III Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02352584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*